Life Sciences Products Liability
Products liability built for supplement, device, pharmaceutical, and biologic makers.
This is an estimate, not a bound policy — a licensed VAB producer confirms final terms before coverage starts. Sgt. Savings can answer questions but can't quote, bind, or guarantee coverage.
Life Sciences Products Liability extends products liability coverage to the categories a standard products policy treats with extra caution — dietary supplements and nutritional products, medical devices, prescription and OTC pharmaceuticals, and biologics like vaccines and cell or gene therapies. Businesses in these categories face heavier regulatory scrutiny and a different injury profile than a general manufacturer, and this coverage is scoped for that reality, including a path to preserve coverage when a product was fully compliant at the time it left your hands.
Who This Is Really For
The ideal buyer.
The ideal buyer is a supplement, device, pharmaceutical, or biologics company preparing for a specific regulatory or commercial milestone — a new product launch pending clearance, a renewal cycle tied to a fresh FDA approval, or a scale-up from clinical to commercial production. The trigger is often watching a competitor's recall or regulatory action make headlines and realizing a standard products policy either excludes their category outright or treats it too narrowly to matter. This buyer has usually already tried a general manufacturer's products policy and found the regulatory and injury profile of their category — contamination, adverse reaction, device malfunction — wasn't really what that policy was built to underwrite. What fits them here is coverage that treats their product category as the normal case, not the exception, including a path to preserve coverage for a product that was fully compliant when it left their hands even if the regulatory picture changes later.
- Dietary supplement, vitamin, mineral, and herbal product makers
- Medical device manufacturers, including devices with required companion software
- Prescription and over-the-counter pharmaceutical companies
- Biologics manufacturers — vaccines, blood products, cell, gene, and tissue-based products
- Companies whose product category faces frequent FDA or agency scrutiny
- Businesses that need coverage to survive a later regulatory action against a product that was compliant when sold
What It Covers
Coverage, broken down.
Expanded product-category scope
Broadens standard products coverage to reach supplements, medical devices, pharmaceuticals, and biologics — categories a general products policy often treats narrowly or excludes.
Regulatory Carve-Back (optional)
When elected, restores bodily-injury and property-damage coverage, subject to a separate sublimit, for a product that had every required FDA or agency approval, clearance, license, or registration at the time it left the company's possession — even if a later regulatory action is taken against that product.
Illustrative Scenario — How This Coverage Responds
Illustrative scenario — a supplement recall years after sale
A supplement maker's product was fully compliant with every labeling and manufacturing requirement in place at the time it shipped. Years later, a regulatory review flags a contamination concern tied to that batch, and injury claims follow. Because the product was compliant when it left the company's possession, the Regulatory Carve-Back can preserve coverage for the underlying bodily-injury claims — subject to its own sublimit — even though the regulatory landscape shifted after the sale.
Illustrative example for education only — not a claim outcome or a promise of payment. Every claim depends on the actual policy issued and its terms.
More Than One Way In
More scenarios.
Real coverage doesn't fit one story. Here's who else this shows up for.
The new SKU launch
A supplement company preparing to launch a new product line wants to confirm the product is treated as covered from the moment it ships, not added as an afterthought once it's already on shelves.
The clearance renewal cycle
A medical device company renews its coverage around the same time a new FDA clearance takes effect for an updated version of its product, and wants the policy to reflect the current, cleared version accurately.
The clinical-to-commercial scale-up
A cell and gene therapy company moves from small-batch clinical production into full commercial manufacturing, and needs its products liability coverage to keep pace with a very different production and distribution scale.
Know The Gaps
What this doesn't cover.
Every policy has limits. Knowing them before you buy is how you avoid a denied claim later.
Product Warranty and Efficacy claims about therapeutic or clinical performance
A claim that a product simply didn't achieve its intended therapeutic effect is excluded — this policy responds to actual harm, contamination, or inadequate warning, not underperformance claims.
The regulatory action itself — costs of responding, fines, penalties, or agency-brought claims
Even when the Regulatory Carve-Back restores bodily-injury coverage, it doesn't cover the cost of responding to an FDA seizure, recall, or warning letter, or any fine that results from it.
Clinical trials and investigational-use research
All clinical-trial and investigational-use injuries are excluded outright — that exposure needs a dedicated clinical-trial liability policy, not this one.
Asbestos, lead, silica, and PFAS exposure
Excluded as with any standard products policy — a separate environmental conversation if relevant to your operations.
Damage to your own product
This covers harm the product causes elsewhere, not the cost of the product itself.
Behind The Quote
What goes into the decision.
What actually moves your price and your approval — no black box.
Product category
Supplements, devices, pharmaceuticals, and biologics each carry a distinct regulatory and injury profile — the category drives how the policy is structured, since a contamination risk and a device malfunction risk aren't underwritten the same way.
Regulatory status at time of sale
Whether the product held every required FDA or agency approval, clearance, license, or registration when it left the company's possession is the specific fact the Regulatory Carve-Back turns on — keeping that documentation is what makes the carve-back usable later.
Whether the Regulatory Carve-Back is elected
This protection is optional, not automatic — a company in a category with real regulatory-timeline exposure should discuss electing it explicitly rather than assuming it's included.
Manufacturing and contamination controls
Documented quality-control and batch-testing practices are the practical evidence a product met its requirements at the time of sale — the same evidence that supports both underwriting and a later claim.
Let's get you covered.
Tell us what you need on Life Sciences Products Liability — a licensed VAB advisor follows up personally. No bots, no runaround.
Looking for a session that's already scheduled? Browse upcoming webinars.
Availability
Available nationwide, with policy terms adjusted to each state's requirements.
Questions, answered straight
No jargon on life sciences products liability — just what you're actually asking.
It extends coverage specifically to supplement, medical device, pharmaceutical, and biologic products — categories that carry a different regulatory and injury profile than general manufactured goods, plus the option to preserve coverage through a later regulatory action.
If the Regulatory Carve-Back is elected and your product was fully compliant with every required approval at the time it left your possession, bodily-injury coverage can be preserved, subject to a separate sublimit — even though the regulatory landscape shifted afterward.
No — a pure efficacy claim, without actual harm, contamination, or an inadequate warning, is excluded under the Product Warranty and Efficacy exclusion.
No. Clinical trial and investigational-use injuries are excluded outright and need a separate clinical-trial liability policy.
Yes — software required for a medical device's intended use is included in the product category this coverage is scoped to.
It doesn't cover the cost of responding to the regulatory action itself, any fines or penalties, or claims brought by the agency directly — it's specifically about preserving bodily-injury and property-damage coverage for third-party claims.
Beyond This Coverage
What people in your situation also need.
Equipment Financing
Life sciences manufacturers scaling production or adding new quality-control equipment often finance that buildout alongside updating their liability coverage.
ExploreBusiness Banking
A regulated manufacturer needs a business banking relationship built for the same operational complexity that shapes its insurance program.
ExploreRelated Coverage
Coverage people pair with this.
Products & Completed Operations Liability
Coverage for injury or damage your product or finished work causes after it leaves your hands.
Learn morePsychedelic Therapeutics Liability
Liability coverage built for state-licensed psychedelic therapy providers.
Learn moreManaged Care Errors & Omissions
Liability coverage built for how health plans actually get sued — over decisions, not treatment.
Learn moreReady to talk it through?
Get a quote in minutes, or ask Sgt. Savings a straight question first — no pressure, no runaround.
Insurance products described on this page are marketed by The Veteran Alliance, a licensed insurance producer, and underwritten by one or more separately licensed insurance companies, which may include Corgi Insurance Company and its affiliates. The insurer that actually underwrites your policy, its licensing status in your state, and any state-required notices will be identified in your quote and policy documents. Coverage, limits, eligibility, and pricing are determined by the underwriting insurer, may vary by state, and may change. Nothing on this page is a quote, an offer of insurance, a binder, or a guarantee of coverage — coverage takes effect only when a policy is issued.